PRESS REALESE

Next Generation Sequencing (NGS) Market Size, Share to Exhibit Potential CAGR 18.2% Through 2030

Next Generation Sequencing Market

Next Generation Sequencing Market

High-end technological advancements in NGS, surge in applications of NGS, and rise in demand for genome mapping programs drive the growth of the global market.

PORTLAND, OREGON, UNITED STATE, July 14, 2022 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global Next Generation Sequencing (NGS) Market was pegged at $6.59 billion in 2020 and is estimated to hit $35.50 billion by 2030, registering a CAGR of 18.2% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/2048

High-end technological advancements in NGS, surge in applications of NGS, and rise in demand for genome mapping programs drive the growth of the global next generation sequencing (NGS) market. On the other hand, standardization concerns over NGS-based diagnostics, lack of skilled professionals, and several ethical and legal limitations restrain the growth to some extent. However, increase in demand for cloud computing and potential data management services are anticipated to pave the way for lucrative opportunities in the industry.

COVID-19 scenario-

• The NGS diagnostic technology comes with immense potential to determine the genetic sequence of a virus, thereby helping scientists recognize the mutation of the virus. This factor has impacted the NGS market positively.

• At the same time, genome sequencing has also been used to understand the spread of COVID-19, thus improving the treatments.

The global next generation sequencing (NGS) market is analyzed across product, application, technology, end user, and region. Based on product type, the consumables segment accounted for more than two-thirds of the total market revenue in 2020, and is projected to rule the roost by the end of 2030. The services segment, on the other hand, would cite the fastest CAGR of 19.3% throughout the forecast period.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/2048

Based on application, the biomarkers & cancer segment contributed to more than one-third of the total market share in 2020, and is expected to lead the trail by 2030. The agriculture and animal research segment, however, would also grow at the fastest CAGR of 19.2% from 2021 to 2030.

Based on geography, North America held the major share in 2020, garnering around two-fifths of the global market. Simultaneously, the market across Asia-Pacific would exhibit the fastest CAGR of 19.0% by 2030. The other two provinces discussed in the report include Europe and LAMEA.

The leading market players analyzed in the global NGS market report include Inc., BGI Group, F. Hoffmann-La Roche AG, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, PerkinElmer, Inc., Illumina Inc, PierianDx Inc., and Qiagen N.V. These market players have incorporated different strategies including partnership, expansion, collaboration, joint ventures, and others to brace their stand in the industry.

We also Offers Regional and Country Reports-

• Japan Radiotherapy Market
• South Korea Radiotherapy Market
• Singapore Radiotherapy Market
• China Radiotherapy Market
• Indonesia Radiotherapy Market
• Australia Radiotherapy Market
• Taiwan Radiotherapy Market

Trending Reports in Healthcare Industry:

Healthcare CRM Market Analysis & Industry Forecast, 2021 – 2030

Scaffold Technology Market Analysis & Industry Forecast, 2020-2027

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

Benefits of Purchasing Next Generation Sequencing Market Reports:

• Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.

• Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.

• Assured Quality: Focuses on accuracy and quality of reports.

• Incomparable Skills: Analysts provide in-depth insights into reports.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn